Accessibility Menu
Select Medical Stock Quote

Select Medical (NYSE: SEM)

$14.12
(2.2%)
+0.30
Price as of October 22, 2025, 12:14 p.m. ET

KEY DATA POINTS

Current Price
$14.12
Daily Change
(2.2%) +$0.30
Day's Range
$13.87 - $14.2
Previous Close
$13.81
Open
$13.94
Beta
1.07
Volume
187,065
Average Volume
1,130,928
Market Cap
1.7B
Market Cap / Employee
$13.81M
52wk Range
$11.65 - $22.07
Revenue
-
Gross Margin
0.10%
Dividend Yield
1.85%
EPS
$1.07
CAPs Rating
-
Industry
Healthcare Providers and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Select Medical Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
SEM-21.26%+19.8%+3.68%+242%
S&P+15.06%+95.03%+14.29%+545%

Select Medical Company Info

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment offer physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$1.34B-23.9%
Gross Profit$120.60M-41.9%
Gross Margin9.00%-2.8%
Market Cap$1.95B-20.5%
Market Cap / Employee$0.04M0.0%
Employees44.1K-19.2%
Net Income$57.06M-37.6%
EBITDA$119.79M-43.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$52.35M-52.9%
Accounts Receivable$909.46M-15.6%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$2.66B-43.3%
Short Term Debt$218.98M-31.1%

Ratios

Q2 2025YOY Change
Return On Assets1.85%-1.5%
Return On Invested Capital3.36%-0.9%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$45.61M-79.5%
Operating Free Cash Flow$110.29M-60.3%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings16.2711.3712.4314.23-15.15%
Price to Book1.721.271.281.13-36.09%
Price to Sales0.620.370.350.33-47.58%
Price to Tangible Book Value-1.01-1.25-2.86-2.72178.04%
Price to Free Cash Flow TTM15.1010.547.1114.28-26.39%
Enterprise Value to EBITDA47.7694.2235.3142.31-6.20%
Free Cash Flow Yield6.6%9.5%14.1%7.0%35.85%
Return on Equity16.7%13.3%10.4%8.2%-58.07%
Total Debt$4.57B$2.70B$2.79B$2.88B-42.50%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.